Sonim Technologies INC 8-K filings

DNA X, Inc. has filed an amendment to its Form 8-K to update disclosures regarding its equity position and its efforts to meet Nasdaq Capital Market continued listing requirements.

DNA X, Inc. filed an 8-K/A amendment to its previous filing, providing updated pro forma stockholders' equity figures to demonstrate compliance with Nasdaq's minimum equity requirement following a recent financing transaction.

DNA X, Inc. announced a $8.1 million private placement of Series B Convertible Preferred Stock, with $5 million in cash and $3.1 million from note cancellation, to fund working capital.

DNA X, Inc. has mutually agreed with Chardan Capital Markets LLC to terminate its $500 million common stock purchase agreement.

DNA X, Inc. has entered into a Securities Purchase Agreement to issue a convertible note, while simultaneously facing a potential delisting from the Nasdaq Capital Market.

DNA X, Inc. reports Q1 2026 financial results, highlighting the completion of its mobile asset sale and transition to an AI-driven crypto trading platform.

DNA X, Inc. announced its 2025 financial results, detailing the sale of its mobile device assets and the acquisition of the DNA X cryptocurrency trading platform, signaling a strategic pivot.

DNA X, Inc. filed an amendment to its previous 8-K, reclassifying a December 2025 acquisition as not involving a significant amount of assets.

DNA X, Inc. announced the appointment of Mike Mulica as Acting CEO and updated compensation agreements for both Mulica and CFO Clay Crolius, following a recent asset sale.

DNA X, Inc. announced the resignation of its CEO and CCO, Peter Liu and Charles Becher, respectively, and the appointment of Scott Walker to its Board of Directors.

DNA X, Inc., formerly Sonim Technologies, Inc., completed the sale of its 5G solutions business, prepaid $5.4 million in debt, and is now focused on digital asset management.

Sonim Technologies, Inc. stockholders approved the sale of its enterprise 5G solutions business and related executive compensation at a special meeting.

Sonim Technologies, Inc. announced a $1.2 million convertible note financing and the acquisition of DNA X LLC, an on-chain trading protocol, alongside an equity exchange with Streeterville Capital.

Sonim Technologies, Inc. announced a contingent cash retention bonus for its CFO tied to an asset purchase agreement and a substitute cash grant for its Executive Chairman due to insufficient RSU shares.

Sonim Technologies, Inc. amended its asset purchase agreement for its enterprise 5G solutions business, removing the proposed reverse merger and adding its German subsidiary to the sale.

Sonim Technologies, Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement, effectively closing the delisting matter.

Sonim Technologies reported a 45% sequential revenue increase and a narrowed net loss in Q3 2025, driven by new product demand and strategic initiatives including an asset sale and reverse stock split.

Sonim Technologies, Inc. has enacted a 1-for-18 reverse stock split, effective October 27, 2025, to maintain its Nasdaq listing compliance.

Sonim Technologies, Inc. received a Nasdaq delisting notice, secured an extension, appointed Michael Mulica as Executive Chairman, and approved a 1-for-18 reverse stock split.

Sonim Technologies, Inc. has entered into a committed equity facility agreement with Chardan Capital Markets LLC, providing access to up to $500 million in capital.

Sonim Technologies, Inc. received a Nasdaq deficiency letter for failing to meet continued listing requirements, including minimum stockholders' equity.

Sonim Technologies, Inc. received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement, initiating a 180-day period to regain compliance.

Sonim Technologies entered a new factoring agreement for up to EUR 3 million and amended existing subscription agreements to reduce warrant exercise prices to $0.75, while also approving cash grants for directors.

Sonim Technologies reported a significant revenue decline and net loss in Q2 2025, while progressing with a $15 million asset sale to Social Mobile and new product launches.

Sonim Technologies' stockholders re-elected all five Board-nominated directors but rejected the executive compensation package and a proposed equity incentive plan amendment, while approving special cash awards for the Board's special committee.

Sonim Technologies, Inc. has entered into an agreement to sell substantially all assets of its enterprise 5G solutions business for $15 million in cash, with a potential earn-out of up to $5 million, as it plans to pursue a reverse merger.

Sonim Technologies, Inc. has entered into a secured promissory note agreement with Streeterville Capital, LLC for $2.5 million in net proceeds, subject to significant fees, high interest, and restrictive covenants that could severely impact its financial flexibility.

Sonim Technologies, Inc. has successfully priced a best-efforts public offering of 7.4 million common shares at $0.75 per share, anticipating approximately $4.9 million in net proceeds for general corporate purposes.

Sonim Technologies, a provider of rugged mobile solutions, has signed a non-binding Letter of Intent for a reverse takeover with a private AI high-performance computing company, alongside the sale of its legacy operating assets.

Sonim Technologies, Inc. has appointed Baker Tilly US, LLP as its new independent registered public accounting firm, succeeding Moss Adams LLP due to a merger, with no reported disagreements or adverse opinions on past financial statements, though prior material weaknesses persist.